Daniel Shae

1.5k citations
10 papers · 1.1k indexed · 1 hit paper · h-index 9

Impact in

  • Immunology top 5%
    • interferon and immune responses
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
    • Immune Response and Inflammation
  • Biomaterials top 10%

Papers in

    • interferon and immune responses 6
    • Immune Response and Inflammation 3
    • Immunotherapy and Immune Responses 3

Daniel Shae

10 papers receiving 1.1k citations

Hit Papers

Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy 2019 · 540 citations
5402019202620212023100200300400500

Peers

Daniel Shae
Comparison fields: 5 of 66
  • Immunology 848
  • Biomaterials 130
  • Infectious Diseases 174
  • Biomedical Engineering 377
  • Oncology 217
Replace Debra Van Egeren with:
Debra Van Egeren United States
Sema Sevimli Australia
Neil C. Sheppard United States
Elena Dukhovlinova United States
Derfogail Delcassian United States
Ans De Beuckelaer Belgium
Wuhbet Abraham United States
Sandra Van Lint Belgium
Laura Jeanbart Switzerland
Daniel Shae relative to Debra Van Egeren United States Debra Van Egeren's profile →
Citations per field
00.5×1.5×2.2×
Debra Van Egeren · 1×
Citations per year

Countries citing papers authored by Daniel Shae

Since Specialization
Citations

This map shows the geographic impact of Daniel Shae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Shae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Shae more than expected).

Fields of papers citing papers by Daniel Shae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Shae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Shae. The network helps show where Daniel Shae may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Shae, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Shae Line = papers co-authored together Daniel Shae links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Hit paper breakdown →
2019540
2 2020132
3 2020129
4 202092
5 201876
6 201659
7 201954
8 201925
9 202016
10 20196

About Daniel Shae

Daniel Shae is a scholar working on Immunology, Biotechnology, Biomedical Engineering, Biomaterials and Oncology, having authored 10 papers that have together received 1.1k indexed citations. Recurring topics across this work include interferon and immune responses (6 papers), Nanoplatforms for cancer theranostics (3 papers), Immune Response and Inflammation (3 papers), Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Immunology (848 citations), Biomaterials (130 citations), Infectious Diseases (174 citations), Biomedical Engineering (377 citations) and Oncology (217 citations). Daniel Shae has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include John T. Wilson, Kyle W. Becker, Justin M. Balko, Plamen P. Christov, Sema Sevimli, Mark C. Kelley, Abigail K. R. Lytton‐Jean, Douglas B. Johnson, Dong Soo Yun and Manuel Ascano. Their work appears in journals such as ACS Nano, Biomaterials, Journal of Leukocyte Biology, ACS Omega and Advanced Healthcare Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026